<div class="container">

<table style="width: 100%;"><tr>
<td>optimal_multiarm_normal</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Optimal phase II/III drug development planning for multi-arm programs with
normally distributed endpoint</h2>

<h3>Description</h3>

<p>The <code>optimal_multiarm_normal</code> function enables planning of
multi-arm phase II/III drug development programs with optimal sample size
allocation and go/no-go decision rules. For normally distributed endpoints,
the treatment effect is measured by the standardized difference in means
(Delta). So far, only three-arm trials with two treatments and one control
are supported. The assumed true treatment effects can be assumed fixed or
modelled by a prior distribution. The R Shiny application
<a href="https://web.imbi.uni-heidelberg.de/prior/">prior</a> visualizes the
prior distributions used in this package. Fast computing is enabled by
parallel programming.
</p>


<h3>Usage</h3>

<pre><code class="language-R">optimal_multiarm_normal(
  Delta1,
  Delta2,
  n2min,
  n2max,
  stepn2,
  kappamin,
  kappamax,
  stepkappa,
  alpha,
  beta,
  c2,
  c3,
  c02,
  c03,
  K = Inf,
  N = Inf,
  S = -Inf,
  steps1 = 0,
  stepm1 = 0.5,
  stepl1 = 0.8,
  b1,
  b2,
  b3,
  strategy,
  num_cl = 1
)
</code></pre>


<h3>Arguments</h3>

<table>
<tr style="vertical-align: top;">
<td><code>Delta1</code></td>
<td>
<p>assumed true treatment effect as the standardized difference in
means for treatment arm 1</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>Delta2</code></td>
<td>
<p>assumed true treatment effect as the standardized difference in
means for treatment arm 2</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>n2min</code></td>
<td>
<p>minimal total sample size in phase II, must be divisible by 3</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>n2max</code></td>
<td>
<p>maximal total sample size in phase II, must be divisible by 3</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>stepn2</code></td>
<td>
<p>stepsize for the optimization over n2, must be divisible by 3</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>kappamin</code></td>
<td>
<p>minimal threshold value kappa for the go/no-go decision rule</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>kappamax</code></td>
<td>
<p>maximal threshold value  kappa for the go/no-go decision rule</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>stepkappa</code></td>
<td>
<p>step size for the optimization over the threshold value kappa</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>alpha</code></td>
<td>
<p>one-sided significance level/family-wise error rate</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>beta</code></td>
<td>
<p>type-II error rate for any pair, i.e. <code>1 - beta</code> is the (any-pair) power for calculation of the sample size for phase III</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>c2</code></td>
<td>
<p>variable per-patient cost for phase II</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>c3</code></td>
<td>
<p>variable per-patient cost for phase III</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>c02</code></td>
<td>
<p>fixed cost for phase II</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>c03</code></td>
<td>
<p>fixed cost for phase III</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>K</code></td>
<td>
<p>constraint on the costs of the program, default: <code>Inf</code>, e.g. no constraint</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>N</code></td>
<td>
<p>constraint on the total expected sample size of the program, default: <code>Inf</code>, e.g. no constraint</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>S</code></td>
<td>
<p>constraint on the expected probability of a successful program, default: <code>-Inf</code>, e.g. no constraint</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>steps1</code></td>
<td>
<p>lower boundary for effect size category "small", default: 0</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>stepm1</code></td>
<td>
<p>lower boundary for effect size category "medium" = upper boundary for effect size category "small" default: 0.5</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>stepl1</code></td>
<td>
<p>lower boundary for effect size category "large" = upper boundary for effect size category "medium", default: 0.8</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>b1</code></td>
<td>
<p>expected gain for effect size category "small"</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>b2</code></td>
<td>
<p>expected gain for effect size category "medium"</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>b3</code></td>
<td>
<p>expected gain for effect size category "large"</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>strategy</code></td>
<td>
<p>choose strategy: 1 (only the best promising candidate), 2 (all promising candidates) or 3 (both strategies)</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>num_cl</code></td>
<td>
<p>number of clusters used for parallel computing, default: 1</p>
</td>
</tr>
</table>
<h3>Value</h3>

<p>The output of the function is a <code>data.frame</code> object containing the optimization results:
</p>
<dl>
<dt>Strategy</dt>
<dd>
<p>Strategy, 1: "only best promising" or 2: "all promising"</p>
</dd>
<dt>u</dt>
<dd>
<p>maximal expected utility under the optimization constraints, i.e. the expected utility of the optimal sample size and threshold value</p>
</dd>
<dt>Kappa</dt>
<dd>
<p>optimal threshold value for the decision rule to go to phase III</p>
</dd>
<dt>n2</dt>
<dd>
<p>total sample size for phase II; rounded to the next even natural number</p>
</dd>
<dt>n3</dt>
<dd>
<p>total sample size for phase III; rounded to the next even natural number</p>
</dd>
<dt>n</dt>
<dd>
<p>total sample size in the program; n = n2 + n3</p>
</dd>
<dt>K</dt>
<dd>
<p>maximal costs of the program (i.e. the cost constraint, if it is set or the sum K2+K3 if no cost constraint is set)</p>
</dd>
<dt>pgo</dt>
<dd>
<p>probability to go to phase III</p>
</dd>
<dt>sProg</dt>
<dd>
<p>probability of a successful program</p>
</dd>
<dt>sProg2</dt>
<dd>
<p>probability of a successful program with two arms in phase III</p>
</dd>
<dt>sProg3</dt>
<dd>
<p>probability of a successful program with three arms in phase III</p>
</dd>
<dt>K2</dt>
<dd>
<p>expected costs for phase II</p>
</dd>
<dt>K3</dt>
<dd>
<p>expected costs for phase III</p>
</dd>
</dl>
<p>and further input parameters. Taking <code>cat(comment())</code> of the
data frame lists the used optimization sequences, start and
finish date of the optimization procedure.
</p>


<h3>References</h3>

<p>Cohen, J. (1988). Statistical power analysis for the behavioral sciences.
</p>


<h3>Examples</h3>

<pre><code class="language-R"># Activate progress bar (optional)
## Not run: progressr::handlers(global = TRUE)
# Optimize

optimal_multiarm_normal(Delta1 = 0.375, Delta2 = 0.625,     
  n2min = 20, n2max = 100, stepn2 = 4,                 # define optimization set for n2
  kappamin = 0.02, kappamax = 0.2, stepkappa = 0.02,   # define optimization set for kappa
  alpha = 0.025, beta = 0.1,                           # drug development planning parameters
  c2 = 0.675, c3 = 0.72, c02 = 15, c03 = 20,           # fixed/variable costs for phase II/III
  K = Inf, N = Inf, S = -Inf,                          # set constraints
  steps1 = 0,                                          # define lower boundary for "small"
  stepm1 = 0.5,                                        # "medium"
  stepl1 = 0.8,                                        # and "large" effect size categories
  b1 = 3000, b2 = 8000, b3 = 10000,                    # define expected benefits 
  strategy = 1,
  num_cl = 1)                                          # number of cores for parallelized computing 
  
</code></pre>


</div>